These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 19208518

  • 1. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM, Qiu TS, Bian J, Liu SF, Wang CZ.
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [Abstract] [Full Text] [Related]

  • 2. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 3. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW.
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT.
    Radiology; 2003 Sep; 228(3):719-26. PubMed ID: 12881583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A computer-aided diagnostic system to discriminate SPIO-enhanced magnetic resonance hepatocellular carcinoma by a neural network classifier.
    Guo D, Qiu T, Bian J, Kang W, Zhang L.
    Comput Med Imaging Graph; 2009 Dec; 33(8):588-92. PubMed ID: 19656655
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model.
    Xu H, Xie JX, Li X, Yang ZH, Zheng ZZ, Wang B, Wang Z.
    J Magn Reson Imaging; 2008 Jan; 27(1):102-9. PubMed ID: 18022847
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.
    Kim YK, Kim CS, Han YM, Park G, Hwang SB, Yu HC.
    Clin Radiol; 2010 May; 65(5):358-65. PubMed ID: 20380933
    [Abstract] [Full Text] [Related]

  • 17. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
    Ma HL, Xu YF, Qi XR, Maitani Y, Nagai T.
    Int J Pharm; 2008 Apr 16; 354(1-2):217-26. PubMed ID: 18191350
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?
    Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.
    J Magn Reson Imaging; 2008 Apr 16; 27(4):834-9. PubMed ID: 18383261
    [Abstract] [Full Text] [Related]

  • 20. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
    Guo L, Liang C, Yu T, Wang G, Li N, Sun H, Gao F, Liu C.
    Clin Radiol; 2012 Apr 16; 67(4):319-28. PubMed ID: 22099524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.